| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |